Evogene Ltd. Logo

Evogene Ltd.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Evogene develops computational predictive biology solutions for agriculture, health, and sustainability.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 16:00
Regulatory News Service
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 135.0 KB
2025-08-12 16:00
Foreign Filer Report
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 36.6 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 63.2 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 36.5 KB
2025-07-29 16:00
Report Publication Announcement
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 217.6 KB
2025-07-29 16:00
Report Publication Announcement
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 36.5 KB
2025-07-18 01:00
Foreign Filer Report
Other Report or Announcement
English 180.7 KB
2025-07-18 01:00
Proxy Solicitation & Information Statement
Other Report or Announcement
English 36.7 KB
2025-07-08 16:00
Foreign Filer Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 173.8 KB
2025-07-08 16:00
Foreign Filer Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 36.6 KB
2025-06-18 01:01
Proxy Solicitation & Information Statement
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 708.7 KB
2025-06-18 01:01
Report Publication Announcement
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 36.4 KB
2025-06-18 01:00
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
Foreign Filer Report
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 140.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Herantis Pharma Oyj Logo Herantis Pharma Oyj Finland HRTIS
Hiron-Trade Investments & Industrial Buildings Ltd. Israel HRON
Human Stem Cells Institute PJSC Logo Human Stem Cells Institute PJSC Russian Federation ISKJ
Human Xtensions Ltd. Logo Human Xtensions Ltd. Israel HUMX
Hybrigenics SA Logo Hybrigenics SA France ALHYG
Hyloris Pharmaceuticals SA Logo Hyloris Pharmaceuticals SA Belgium HYL
Ikonisys S.A. Logo Ikonisys S.A. France ALIKO
IMCB PJSC Logo IMCB PJSC Russian Federation GEMA
Immunic AG Logo Immunic AG United States of America IMUX
Incanthera plc United Kingdom N/A